The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval.
So far, 40 novel drugs have been approved for this year, compared to just 22 in 2016. Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.
Let's take a look at the drugs that crossed the regulatory finish line in November.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com